DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▲ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0028754 | Obesity | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C1306459 | Primary malignant neoplasm | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0023890 | Liver Cirrhosis | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0024809 | Marijuana Abuse | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0033578 | Prostatic Neoplasms | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0006826 | Malignant Neoplasms | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0037268 | Skin Abnormalities | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0234398 | Visual Cortex Disorder | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0175694 | Smith-Lemli-Opitz Syndrome | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0017636 | Glioblastoma | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0009171 | Cocaine Abuse | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0028756 | Obesity, Morbid | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0036572 | Seizures | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0027651 | Neoplasms | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0342731 | Deficiency of mevalonate kinase | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C2239176 | Liver carcinoma | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0398691 | Hyperimmunoglobulinemia D | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0020473 | Hyperlipidemia | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0006870 | Cannabis Dependence | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0684249 | Carcinoma of lung | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0025202 | melanoma | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0006868 | Cannabis Abuse | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C2711227 | Steatohepatitis | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0031391 | Phencyclidine Abuse | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
C0011603 | Dermatitis | FDFT1 | 2222 | farnesyl-diphosphate farnesyltransferase 1 | P37268 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024